| Primary |
| In Vitro Fertilisation |
27.0% |
| Product Used For Unknown Indication |
24.3% |
| Ovulation Induction |
16.1% |
| Infertility |
10.8% |
| Assisted Fertilisation |
5.8% |
| Infertility Female |
3.5% |
| Anovulatory Cycle |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Amenorrhoea |
1.3% |
| Hypogonadism Male |
1.2% |
| Polycystic Ovaries |
1.2% |
| Ovarian Disorder |
1.1% |
| Ovarian Hyperstimulation Syndrome |
1.0% |
| Artificial Insemination By Partner |
0.6% |
| In Vitro Fertilization |
0.5% |
| Abortion Spontaneous |
0.5% |
| Azoospermia |
0.5% |
| Hypothyroidism |
0.5% |
| Off Label Use |
0.5% |
| Secondary Hypogonadism |
0.5% |
|
| Ovarian Hyperstimulation Syndrome |
15.2% |
| Abortion Missed |
10.4% |
| Abortion Spontaneous |
9.1% |
| Drug Exposure During Pregnancy |
6.9% |
| Vomiting |
6.1% |
| Stillbirth |
5.6% |
| Twin Pregnancy |
5.6% |
| Vaginal Haemorrhage |
4.8% |
| Ectopic Pregnancy |
4.3% |
| Pregnancy |
4.3% |
| Drug Ineffective |
3.5% |
| Pulmonary Embolism |
3.5% |
| Melanoma Recurrent |
3.0% |
| Pleural Effusion |
3.0% |
| Abortion |
2.6% |
| Breast Cancer |
2.6% |
| Loss Of Consciousness |
2.6% |
| Pancreatitis Acute |
2.6% |
| Adverse Event |
2.2% |
| Ascites |
2.2% |
|
| Secondary |
| In Vitro Fertilisation |
33.2% |
| Product Used For Unknown Indication |
16.4% |
| Infertility |
13.1% |
| Ovulation Induction |
10.6% |
| Artificial Insemination By Partner |
3.4% |
| Infertility Female |
3.2% |
| Assisted Fertilisation |
2.8% |
| Polycystic Ovaries |
2.8% |
| Anovulatory Cycle |
2.3% |
| Multiple Sclerosis |
2.0% |
| Azoospermia |
1.8% |
| Endometriosis |
1.7% |
| Ovarian Hyperstimulation Syndrome |
1.3% |
| Hormone Therapy |
1.0% |
| Ovarian Disorder |
1.0% |
| Drug Use For Unknown Indication |
0.8% |
| Hypogonadism Male |
0.7% |
| Luteal Phase Deficiency |
0.7% |
| Superovulation |
0.7% |
| Amenorrhoea |
0.5% |
|
| Ovarian Hyperstimulation Syndrome |
13.1% |
| Premature Baby |
12.4% |
| Abortion Missed |
10.3% |
| Abortion Spontaneous |
6.9% |
| Pleural Effusion |
6.9% |
| Ectopic Pregnancy |
5.5% |
| Melanoma Recurrent |
5.5% |
| Vomiting |
4.8% |
| Drug Exposure Before Pregnancy |
4.1% |
| Vaginal Haemorrhage |
4.1% |
| Breast Cancer |
3.4% |
| Pregnancy |
3.4% |
| Headache |
2.8% |
| Stillbirth |
2.8% |
| Twin Pregnancy |
2.8% |
| Ureteric Obstruction |
2.8% |
| Influenza |
2.1% |
| Metastases To Central Nervous System |
2.1% |
| Ovarian Torsion |
2.1% |
| Pain |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.4% |
| In Vitro Fertilisation |
32.8% |
| Infertility |
6.0% |
| Blood Follicle Stimulating Hormone Decreased |
3.4% |
| Blood Luteinising Hormone Decreased |
3.4% |
| Ovulation Induction |
2.1% |
| Prevention Of Premature Ovulation |
2.1% |
| Growth Hormone Deficiency |
1.3% |
| Hypopituitarism |
0.9% |
| Assisted Fertilisation |
0.4% |
| Blood Follicle Stimulating Hormone |
0.4% |
| Blood Gonadotrophin Abnormal |
0.4% |
| Blood Prolactin Increased |
0.4% |
| Endometrial Disorder |
0.4% |
| Hereditary Disorder |
0.4% |
| Hyperprolactinaemia |
0.4% |
| Hypothyroidism |
0.4% |
| Infertility Male |
0.4% |
| Prophylaxis Of Abortion |
0.4% |
| Thyroid Disorder |
0.4% |
|
| Ovarian Hyperstimulation Syndrome |
10.3% |
| Fatigue |
7.7% |
| Headache |
7.7% |
| Meningioma |
7.7% |
| Paraesthesia |
7.7% |
| Epilepsy |
5.1% |
| Foetal Exposure During Pregnancy |
5.1% |
| Gastric Ulcer |
5.1% |
| Hepatic Function Abnormal |
5.1% |
| Off Label Use |
5.1% |
| Pneumonia |
5.1% |
| Uterine Cancer |
5.1% |
| Vision Blurred |
5.1% |
| Anxiety |
2.6% |
| Arthralgia |
2.6% |
| Depression |
2.6% |
| Dizziness |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Drug Ineffective |
2.6% |
| Exposure During Pregnancy |
2.6% |
|
| Interacting |
| In Vitro Fertilisation |
100.0% |
|
| Ovarian Hyperstimulation Syndrome |
66.7% |
| Exposure During Pregnancy |
33.3% |
|
